BAMF
ALNY icon

BI Asset Management Fondsmaeglerselskab’s Alnylam Pharmaceuticals ALNY Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14M Buy
7,097
+1,400
+25% +$422K 0.02% 405
2026
Q1 		$1.89M Sell
5,697
-9,172
-62% -$3.12M 0.02% 399
2025
Q4 		$5.91M Buy
14,869
+8,164
+122% +$3.61M 0.05% 233
2025
Q3 		$3.06M Sell
6,705
-207
-3% -$84.3K 0.03% 334
2025
Q2 		$2.25M Buy
6,912
+1,570
+29% +$434K 0.02% 343
2025
Q1 		$1.44M Sell
5,342
-6,413
-55% -$1.65M 0.02% 369
2024
Q4 		$2.77M Buy
11,755
+3,232
+38% +$850K 0.03% 299
2024
Q3 		$2.34M Buy
8,523
+3,961
+87% +$1.03M 0.04% 260
2024
Q2 		$1.11M Buy
4,562
+838
+23% +$132K 0.02% 378
2024
Q1 		$557K Sell
3,724
-45
-1% -$7.51K 0.01% 504
2023
Q4 		$721K Buy
3,769
+2,076
+123% +$354K 0.02% 459
2023
Q3 		$300K Sell
1,693
-516
-23% -$98.4K 0.01% 565
2023
Q2 		$420K Sell
2,209
-9,853
-82% -$1.95M 0.01% 516
2023
Q1 		$2.42M Buy
12,062
+6,432
+114% +$1.35M 0.06% 206
2022
Q4 		$1.34M Buy
5,630
+2,721
+94% +$580K 0.04% 280
2022
Q3 		$582K Sell
2,909
-221
-7% -$42.2K 0.03% 263
2022
Q2 		$457K Buy
3,130
+1,262
+68% +$179K 0.02% 330
2022
Q1 		$305K Buy
+1,868
New +$285K 0.01% 353
2020
Q4 		– Sell
-293
Closed -$43K – 380
2020
Q3 		$43K Buy
+293
New +$41.6K ﹤0.01% 444

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's ALNY Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab increased its Alnylam Pharmaceuticals (ALNY) stake by 25% in Q2 2026, buying an estimated $422K and bringing the position to 7,097 shares worth $2.14M. The position accounts for 0.02% of the portfolio, ranked #405.

BI Asset Management Fondsmaeglerselskab first reported a position in ALNY in Q3 2020 and has held it in 19 quarters since. The position peaked at $5.91M in Q4 2025. 496 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • BI Asset Management Fondsmaeglerselskab held 7,097 shares of Alnylam Pharmaceuticals worth $2.14M as of Q2 2026.
  • BI Asset Management Fondsmaeglerselskab bought 1,400 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $422K.
  • Alnylam Pharmaceuticals made up 0.02% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #405 holding.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Alnylam Pharmaceuticals in Q3 2020 and has held it in 19 quarters since.
  • BI Asset Management Fondsmaeglerselskab's Alnylam Pharmaceuticals position peaked at $5.91M in Q4 2025.
  • 496 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.